Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (471-480 of 548) with videos related to

Pageof 55
Sort By:
Experimental Brain Research|September 1, 2000
Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmosetP Jenner, B Y Zeng, L A Smith, et al.
Molecular Pharmacology|September 1, 1986
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptorsG J Kilpatrick, N el Tayar, H Van de Waterbeemd, et al.
Journal of Neurochemistry|July 2, 1998
Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodiesL Lyras, R H Perry, E K Perry, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in ratsP Jenner, R Kerwin, N M Rupniak, et al.
Journal of Neural Transmission. General Section|January 1, 1995
Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activityK K Gnanalingham, N A Milkowski, L A Smith, et al.
Advances in Neurology|January 1, 1987
Pathology of MPTP in the marmosetW R Gibb, A J Lees, F R Wells, et al.
Clinical Neuropharmacology|June 1, 1994
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's diseaseS Rose, J G Hindmarsh, M J Steiger, et al.
Lancet (London, England)|November 4, 1989
Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trialR D Elwes, H Crewes, L P Chesterman, et al.
Journal of Neurochemistry|June 1, 1989
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseD T Dexter, F R Wells, A J Lees, et al.
Clinical Neuropharmacology|January 1, 1986
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapineN M Rupniak, R S Briggs, M M Petersen, et al.
Pageof 55

Showing results (471-480 of 548) with videos related to

Sort By:
Pageof 55
Experimental Brain Research|September 1, 2000
Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmosetP Jenner, B Y Zeng, L A Smith, et al.
Molecular Pharmacology|September 1, 1986
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptorsG J Kilpatrick, N el Tayar, H Van de Waterbeemd, et al.
Journal of Neurochemistry|July 2, 1998
Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodiesL Lyras, R H Perry, E K Perry, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in ratsP Jenner, R Kerwin, N M Rupniak, et al.
Journal of Neural Transmission. General Section|January 1, 1995
Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activityK K Gnanalingham, N A Milkowski, L A Smith, et al.
Advances in Neurology|January 1, 1987
Pathology of MPTP in the marmosetW R Gibb, A J Lees, F R Wells, et al.
Clinical Neuropharmacology|June 1, 1994
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's diseaseS Rose, J G Hindmarsh, M J Steiger, et al.
Lancet (London, England)|November 4, 1989
Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trialR D Elwes, H Crewes, L P Chesterman, et al.
Journal of Neurochemistry|June 1, 1989
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseD T Dexter, F R Wells, A J Lees, et al.
Clinical Neuropharmacology|January 1, 1986
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapineN M Rupniak, R S Briggs, M M Petersen, et al.
Pageof 55